XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)        
Revenue $ 4,906 $ 2,582 $ 8,698 $ 4,778
Operating Expenses        
Direct costs 6,897 2,987 13,171 5,017
Research and development 14,508 8,440 26,156 15,101
Selling, general and administrative 5,673 5,851 12,862 10,670
Total operating expenses 27,078 17,278 52,189 30,788
Operating Loss (22,172) (14,696) (43,491) (26,010)
Nonoperating Income and Expense        
Interest income 4,993 931 9,827 1,171
Change in fair value of warrant liabilities 4,987 27,473 2,325 28,183
Interest expense (13) (5) (26) (10)
Total nonoperating income and expense 9,967 28,399 12,126 29,344
Pretax Income (Loss) (12,205) 13,703 (31,365) 3,334
Income tax benefit   36   13
Net Income (Loss) Attributable to Common Stockholders (12,205) 13,667 (31,365) 3,321
Other Comprehensive Income (Loss) 1,098 (961) (213) (1,291)
Comprehensive Income (Loss) Attributable to Common Stockholders $ (11,107) $ 12,706 $ (31,578) $ 2,030
Earnings (loss) per share - Basic $ (0.07) $ 0.08 $ (0.18) $ 0.02
Earnings (loss) per share - Diluted $ (0.07) $ 0.08 $ (0.18) $ 0.02
Weighted average shares outstanding - Basic 178,063,573 174,128,230 177,502,037 173,266,760
Weighted average shares outstanding - Diluted 178,063,573 174,703,533 177,502,037 173,566,001